Atropos Health Announces Strategic Financing To Fund International Expansion And Support Key Channel Partnerships
Atropos Health Announces Strategic Financing To Fund International Expansion And Support Key Channel Partnerships
09/23/23, 6:50 PM
Location
palo altoIndustry
medical
health care
Investors
Audere Capital, Gaingels, Samsung Next, Presidio Ventures
Atropos Health, a pioneer in evidence-based healthcare known for its Green Button Clinical Informatics Consult Service, today announced that it has completed a strategic financing from Presidio Ventures, the venture arm of Sumitomo Corporation Venture Group, Samsung Next, a venture arm of Samsung Electronics, Gaingels, Audere Capital, and others. The funding enables Atropos Health to accelerate commercial and development opportunities outside the U.S., using its proprietary technology and approach. Initial focus centers on key customers in Japan and Brazil.
Company Info
Location
169 madison avenue
palo alto, california, united states
Additional Info
Atropos Health is the developer of the first physician consultation service powered by publication-grade real-world evidence. Using millions of anonymized patient records, we help providers answer clinical questions that have fallen through the cracks of the evidence-based literature. The company spun out of the School of Medicine at Stanford University in 2020 after a successful multi-year pilot that generated new evidence across 18 clinical specialties.